Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justyna Rak

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Nature Cancer|August 7, 2023
Different niches for stem cells carrying the same oncogenic driver affect pathogenesis and therapy response in myeloproliferative neoplasmsElodie Grockowiak, Claudia Korn, Justyna Rak, et al.
Blood|June 25, 2025
Posttranscriptional depletion of ribosome biogenesis factors engenders therapeutic vulnerabilities in NPM1-mutant AMLAristi Damaskou, Rachael Wilson, Malgorzata Gozdecka, et al.
Nature Biotechnology|April 24, 2025
Treatment of acute myeloid leukemia models by targeting a cell surface RNA-binding proteinBenson M George, Maria Eleftheriou, Eliza Yankova, et al.
Nature|April 16, 2025
Mitochondrial metabolism sustains DNMT3A-R882-mutant clonal haematopoiesisMalgorzata Gozdecka, Monika Dudek, Sean Wen, et al.
Nature Genetics|August 28, 2025
Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesisMatthew A McLoughlin, Sruthi Cheloor Kovilakam, William G Dunn, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Nature Cancer|August 7, 2023
Different niches for stem cells carrying the same oncogenic driver affect pathogenesis and therapy response in myeloproliferative neoplasmsElodie Grockowiak, Claudia Korn, Justyna Rak, et al.
Blood|June 25, 2025
Posttranscriptional depletion of ribosome biogenesis factors engenders therapeutic vulnerabilities in NPM1-mutant AMLAristi Damaskou, Rachael Wilson, Malgorzata Gozdecka, et al.
Nature Biotechnology|April 24, 2025
Treatment of acute myeloid leukemia models by targeting a cell surface RNA-binding proteinBenson M George, Maria Eleftheriou, Eliza Yankova, et al.
Nature|April 16, 2025
Mitochondrial metabolism sustains DNMT3A-R882-mutant clonal haematopoiesisMalgorzata Gozdecka, Monika Dudek, Sean Wen, et al.
Nature Genetics|August 28, 2025
Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesisMatthew A McLoughlin, Sruthi Cheloor Kovilakam, William G Dunn, et al.
Pageof 2